NCT06406049Recruiting
Finishing HIV Project
FINISHING HIV: An Ending the HIV Epidemic (EHE) Model for Latinx Integrating One-Stop-Shop Pre-Exposure Prophylaxis (PrEP) Services, a Social Network Support Program and a National Pharmacy Chain
Source: ClinicalTrials.gov · Last updated 20 Apr 2026
Brief summary (registry, in English)
This study aims to learn how to help enable healthy behaviors and lower the risk of HIV among Latinx Men.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 624 (estimated)
- First submitted
- 2 May 2024
- Start date
- 8 Nov 2024
- Primary completion date
- 31 May 2030
- Lead sponsor
- University of Miami
- Diseases
- HIV
- NCT number
- NCT06406049
What you commit to
- Study type: Interventional
- Planned participants: 624
- From 8 Nov 2024 to the primary completion date, 31 May 2030
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Display diminished capacity to consent because of:
- An inability to provide informed consent (e.g., cognitive impairment)
- Severe psychiatric symptoms (e.g., mania, psychosis) that impair capacity to provide informed consent, as assessed by interviewers with Collaborative Institutional Training Initiative (CITI) Human Subjects Research and National Institutes of Health (NIH) Good Clinical Practice training
- Self-reported living with HIV
- Reactive HIV test (for "Amigx" seeds or "Yo Quiero" control participants)
- Refusal of HIV test
Age
- \<18 years old or \>54 years old
Other
- Identifies as Non-Latinx
- Individuals enrolled in other PrEP initiation interventions
- Individuals with an active PrEP prescription in the last 6-months (oral or injectable)
Who the study is looking for
- Provision of signed and dated informed consent form
- Stated willingness to comply with all study procedures and availability for the duration of the study
- Being 18 to 54 years of age
- Being a cis-gender male
- Self-report one or more of the following behaviors and health conditions in the last 6 months which meet the Centers for Disease Control and Prevention (CDC) clinical guidelines for PrEP eligibility
- Diagnosed with bacterial sexually transmitted infection (e.g., syphilis, gonorrhea, or chlamydia)
- Sex with a partner who is living with HIV
- Sex without a condom with two or more partners whose HIV status were unknown
- Injection drug use and sharing injection equipment
- Self-reported status as HIV negative
- Willing to be tested for HIV
Age in the registry: 18 years to 54 years · Sex: Male · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Miami Coordinator of this site? Confirm its status | Miami | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.